1 |
dpavlin |
1.1 |
<p><b>High Throughput Screening - a Strategy for Drug Discovery</b></p> |
2 |
|
|
<p>The year 2000 has been a landmark year for science and medicine, and will leave |
3 |
|
|
an indelible mark on the process of drug discovery, as well. The drugs developed |
4 |
|
|
over the last four decades have been aimed at about 500 different biological |
5 |
|
|
targets. With the sequencing of the human genome, over 100,000 new biological |
6 |
|
|
targets will be recognized. It has been estimated that at least 10 % of these |
7 |
|
|
could be potential targets for drugs. This means additional problems for the |
8 |
|
|
already "thinly-spread" drug industry.</p> |
9 |
|
|
<p>High throughput screening (HTS) is a system for analyzing compound libraries |
10 |
|
|
and natural products in order to identify new therapeutic hits and leads on |
11 |
|
|
potential targets. HTS arose in the 1990s as 96 well microtitre plates were |
12 |
|
|
selected over test tubes as the receptacle of choice for biological assays. |
13 |
|
|
In combination with combinatorial chemistry, it resulted in a paradigm shift |
14 |
|
|
from knowledge-based sequential synthesis and testing to parallel processing |
15 |
|
|
of multiple compounds. With the objective to improve success rates and cycle |
16 |
|
|
times for discovering new hits, HTS is set to become one of the cornerstones |
17 |
|
|
of drug discovery.</p> |
18 |
|
|
<p>No matter what technologies are implemented in the HTS process, the goal is |
19 |
|
|
two-fold: to increase the company's drug-screening capacity and to reduce the |
20 |
|
|
consumption of costly reagents.</p> |
21 |
|
|
<p align="center"><img src="p/Finernd_ljudi_9.jpg" width="300" height="380" border=1></p> |